Artificial intelligence fails to improve colonoscopy quality: A single centre retrospective cohort study

Naeman Goetz, Katherine Hanigan, Richard Kai-Yuan Cheng
{"title":"Artificial intelligence fails to improve colonoscopy quality: A single centre retrospective cohort study","authors":"Naeman Goetz, Katherine Hanigan, Richard Kai-Yuan Cheng","doi":"10.37126/aige.v4.i2.18","DOIUrl":null,"url":null,"abstract":"BACKGROUND\n Limited data currently exists on the clinical utility of Artificial Intelligence Assisted Colonoscopy (AIAC) outside of clinical trials.\n AIM\n To evaluate the impact of AIAC on key markers of colonoscopy quality compared to conventional colonoscopy (CC).\n METHODS\n This single-centre retrospective observational cohort study included all patients undergoing colonoscopy at a secondary centre in Brisbane, Australia. CC outcomes between October 2021 and October 2022 were compared with AIAC outcomes after the introduction of the Olympus Endo-AID module from October 2022 to January 2023. Endoscopists who conducted over 50 procedures before and after AIAC introduction were included. Procedures for surveillance of inflammatory bowel disease were excluded. Patient demographics, proceduralist specialisation, indication for colonoscopy, and colonoscopy quality metrics were collected. Adenoma detection rate (ADR) and sessile serrated lesion detection rate (SSLDR) were calculated for both AIAC and CC.\n RESULTS\n The study included 746 AIAC procedures and 2162 CC procedures performed by seven endoscopists. Baseline patient demographics were similar, with median age of 60 years with a slight female predominance (52.1%). Procedure indications, bowel preparation quality, and caecal intubation rates were comparable between groups. AIAC had a slightly longer withdrawal time compared to CC, but the difference was not statistically significant. The introduction of AIAC did not significantly change ADR (52.1% for AIAC vs 52.6% for CC, P = 0.91) or SSLDR (17.4% for AIAC vs 18.1% for CC, P = 0.44).\n CONCLUSION\n The implementation of AIAC failed to improve key markers of colonoscopy quality, including ADR, SSLDR and withdrawal time. Further research is required to assess the utility and cost-efficiency of AIAC for high performing endoscopists.","PeriodicalId":186586,"journal":{"name":"Artificial Intelligence in Gastrointestinal Endoscopy","volume":"38 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial Intelligence in Gastrointestinal Endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37126/aige.v4.i2.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Limited data currently exists on the clinical utility of Artificial Intelligence Assisted Colonoscopy (AIAC) outside of clinical trials. AIM To evaluate the impact of AIAC on key markers of colonoscopy quality compared to conventional colonoscopy (CC). METHODS This single-centre retrospective observational cohort study included all patients undergoing colonoscopy at a secondary centre in Brisbane, Australia. CC outcomes between October 2021 and October 2022 were compared with AIAC outcomes after the introduction of the Olympus Endo-AID module from October 2022 to January 2023. Endoscopists who conducted over 50 procedures before and after AIAC introduction were included. Procedures for surveillance of inflammatory bowel disease were excluded. Patient demographics, proceduralist specialisation, indication for colonoscopy, and colonoscopy quality metrics were collected. Adenoma detection rate (ADR) and sessile serrated lesion detection rate (SSLDR) were calculated for both AIAC and CC. RESULTS The study included 746 AIAC procedures and 2162 CC procedures performed by seven endoscopists. Baseline patient demographics were similar, with median age of 60 years with a slight female predominance (52.1%). Procedure indications, bowel preparation quality, and caecal intubation rates were comparable between groups. AIAC had a slightly longer withdrawal time compared to CC, but the difference was not statistically significant. The introduction of AIAC did not significantly change ADR (52.1% for AIAC vs 52.6% for CC, P = 0.91) or SSLDR (17.4% for AIAC vs 18.1% for CC, P = 0.44). CONCLUSION The implementation of AIAC failed to improve key markers of colonoscopy quality, including ADR, SSLDR and withdrawal time. Further research is required to assess the utility and cost-efficiency of AIAC for high performing endoscopists.
人工智能无法提高结肠镜检查质量:单中心回顾性队列研究
目前,在临床试验之外,人工智能辅助结肠镜检查(AIAC)的临床应用数据有限。目的评价AIAC与常规结肠镜检查(CC)相比对结肠镜检查质量关键指标的影响。方法:这项单中心回顾性观察队列研究纳入了所有在澳大利亚布里斯班二级中心接受结肠镜检查的患者。将2021年10月至2022年10月期间的CC结果与2022年10月至2023年1月引入奥林巴斯Endo-AID模块后的AIAC结果进行比较。在引入AIAC之前和之后进行了超过50次手术的内窥镜医师被包括在内。排除了炎症性肠病的监测程序。收集患者人口统计资料、手术专家、结肠镜检查指征和结肠镜检查质量指标。计算AIAC和CC的腺瘤检出率(ADR)和无根锯齿状病变检出率(SSLDR)。结果研究包括7名内镜医师进行的746例AIAC手术和2162例CC手术。基线患者人口统计学相似,中位年龄为60岁,女性略有优势(52.1%)。手术适应症、肠道准备质量和盲肠插管率在两组之间具有可比性。AIAC的停药时间较CC稍长,但差异无统计学意义。引入AIAC并没有显著改变ADR (AIAC为52.1%,CC为52.6%,P = 0.91)或SSLDR (AIAC为17.4%,CC为18.1%,P = 0.44)。结论AIAC的实施未能改善结肠镜检查质量的关键指标,包括ADR、SSLDR和停药时间。需要进一步的研究来评估AIAC对高性能内窥镜医师的效用和成本效益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书